AUTHOR=Sampson Oliver L. , Jay Cecilia , Adland Emily , Csala Anna , Lim Nicholas , Ebbrecht Stella M. , Gilligan Lorna C. , Taylor Angela E. , George Sherley Sherafin , Longet Stephanie , Jones Lucy C. , Barnes Ellie , Frater John , Klenerman Paul , Dunachie Susie , Carrol Miles , Hawley James , Arlt Wiebke , Groll Andreas , Goulder Philip TITLE=Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents JOURNAL=Frontiers in Immunology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1329805 DOI=10.3389/fimmu.2024.1329805 ISSN=1664-3224 ABSTRACT=
mRNA vaccine technologies introduced following the SARS-CoV-2 pandemic have highlighted the need to better understand the interaction of adjuvants and the early innate immune response. Type I interferon (IFN-I) is an integral part of this early innate response that primes several components of the adaptive immune response. Women are widely reported to respond better than men to tri- and quadrivalent influenza vaccines. Plasmacytoid dendritic cells (pDCs) are the primary cell type responsible for IFN-I production, and female pDCs produce more IFN-I than male pDCs since the upstream pattern recognition receptor Toll-like receptor 7 (TLR7) is encoded by X chromosome and is biallelically expressed by up to 30% of female immune cells. Additionally, the TLR7 promoter contains several putative androgen response elements, and androgens have been reported to suppress pDC IFN-I